Steroid Therapy for Paralytic Deformities in Leprosy

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 65, Issue 3, 1997, Pages 337-344

  Sugumaran, D Samuel Thomson ^a,b  

^a Sacred Heart Leprosy Centre   (India)

^b Schieffelin Leprosy Res/Train Ctr   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE; STEROID;

ACNE; ADOLESCENT; ADULT; ARTICLE; CATARACT; CHILD; DEFORMITY; DIABETES MELLITUS; DRUG INDUCED DISEASE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; LEPROSY; MAJOR CLINICAL STUDY; MALE; MEDIAN NERVE; MOON FACE; MYCOBACTERIOSIS; NERVE PARALYSIS; PEPTIC ULCER; PERONEUS NERVE; SENSORIMOTOR FUNCTION; STEROID THERAPY; TREATMENT OUTCOME; TUBERCULOSIS; ULNAR NERVE;

FEMALE; GLUCOCORTICOIDS; HUMANS; LEPROSY; MALE; MEDIAN NERVE; PARALYSIS; PERONEAL NERVE; PREDNISOLONE; PROSPECTIVE STUDIES; ULNAR NERVE;

EID: 0030661645     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. BECX-BLEUMINK, M. The management of nerve damage in the leprosy control services. Lepr. Rev. 61 (1990) 1-11.
2. BECX-BLEUMINK, M. Priorities for the future and prospects for leprosy control. (Editorial) Int. J. Lepr. 61 (1993) 82-101.
3. BECX-BLEUMINK, M. and BERHE, D. Occurrence of reactions; their diagnosis and management in leprosy patients treated with multidrug therapy, experience in the Leprosy Control Programme of the All Africa Leprosy and Rehabilitation Training Centre (ALERT) in Ethiopia Int. J. Lepr. 60 (1992) 173-184.
4. BELL, J. A. The repeatability of testing with Semmes-Weinstein monofilaments. J. Hand Surg. 12A (1987) 155-161.
5. BIRKE, J. A. and SIMS, D. S. Plantar sensory threshold in the ulcerative foot. Lepr. Rev. 57 (1986) 261-267.
6. BRANDSMA, J. W. Basic nerve function assessments in leprosy patients. Lepr. Rev. 52 (1981) 161-170.
7. GOODWIN, C. S. The use of voluntary muscle testing in leprosy neuritis. Lepr. Rev. 39 (1968) 209-216.
8. GROENEN, G., JANSSENS, L., KAYEMBE, T., NOLLET, E., COUSSENS, L. and PATTYN, S. R. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions. Int. J. Lepr. 54 (1986) 236-244.
9. HAMILTON, J. Deformity prevention in the field; a systematic approach. Lepr. Rev. 54 (1983) 229-237.
10. HAMMOND, C. J. and KLENERMAN, P. Protective sensation in the foot in leprosy. Lepr. Rev. 59 (1988) 347-354.
11. HAYNES, R. C., JR. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs: inhibitors of the synthesis and actions of adrenocortical hormones. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th edn. Gilman, A. G., Rall, T. W., Nies, A. S. and Taylor, P., eds. New York: Pergamon Press, 1990, pp. 1431-1462.
12. JACOBSON, R. R. Treatment. In: Leprosy. Hastings, R. C., ed. Edinburgh: Churchill Livingstone, 1985, p. 198.
13. KIRAN, K. U., STANLEY, J. N. A. and PEARSON, J. M. H. The outpatient treatment of nerve damage in patients with borderline leprosy using a semi-standardised steroid regimen. Lepr. Rev. 56 (1985) 127-134.
14. LEWIS, S. Reproducibility of sensory testing and voluntary muscle testing in evaluating the treatment of acute neuritis in leprosy patients. Lepr. Rev. 54 (1983) 23-30.
15. LOCKWOOD, D. N. J., VINAYAKUMAR, S., STANLEY, J. N. A., MCADAM, K. P. W. J. and COLSTON, M. J. Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India. Int. J. Lepr. 61 (1993) 8-15.
16. MAGORA, A., SHESKIN, J., SAGHER, E. and GONEN, B. The condition of the peripheral nerve in leprosy under various forms of treatment. Int. J. Lepr. 38 (1970) 149-163.
17. NAAFS, B. and DAGNE, T. Sensory testing; a sensitive method in the follow-up of nerve involvement. Int. J. Lepr. 45 (1977) 364-368.
18. NAAFS, B., PEARSON, J. M. H. and BAAR, A. J. M. A follow-up study of nerve lesions in leprosy during and after reactions using motor nerve conduction velocity. Int. J. Lepr. 44 (1976) 188-197.
19. NAAFS, B., PEARSON, J. M. H. and WHEATE, H. W. Reversal reactions: the prevention of nerve damage; comparison of short- and long-term steroid treatment. Int. J. Lepr. 47 (1979) 7-12.
20. NAAFS, B. and WHEATE, H. W. The time interval between the start of antileprosy treatment and the development of reactions in borderline patients. Lepr. Rev. 48 (1978) 153-157.
21. PEARSON, J. M. H. The evaluation of nerve damage in leprosy. Lepr. Rev. 53 (1982) 119-130.
22. PFALTZGRAFF, R. E. Therapy of leprosy. Health Coop. Papers 1 (1981) 121-122.
23. PFALTZGRAFF, R. E. The management of reactions in leprosy. Int. J. Lepr. 57 (1989) 103-109.
24. ROSE, P. and WATEKS, M. F. R. Reversal reactions in leprosy and their management. Lepr. Rev. 62 (1991) 113-121.
25. SHESKIN, J., MAGORA, A. and SAGHER, F. Motor conduction velocity studies in patients with leprosy reactions treated with thalidomide and other drugs. Int. J. Lepr. 37 (1969) 351-364.
26. SRINIVASAN, H. Prevention of disabilities in leprosy - a practical guide. Geneva: World Health Organization, 1993.
27. SRINIVASAN, H., RAO, K. S. and SHANMUGAM, N. Steroid therapy in recent "quiet nerve paralysis" in leprosy-report of a study of twenty-five patients. Lepr. India 54 (1982) 412-419.
28. TOUW-LANGENDIJK, E. M. J., BRANDSMA, J. W. and ANDERSEN, J. G. Treatment of ulnar and median nerve function loss in borderline leprosy. Lepr. Rev. 55 (1984) 41-46.
29. WATSON, J. M. Preventing disability in leprosy patients. London: The Leprosy Mission International, 1986.